DAY 1
8.00 - 9.15am
Opening Ceremony
- Powhiri and address from The Rt Hon. Pita Sharples
- Remarks of welcome from Chief District Court Judge Jan Marie Doogue
9.15am - 10.15am
Addiction and the Brain
Why do people use alcohol and other drugs and how does this affect them? This session will explore the science behind addiction, and what the most current research tells us about this powerful, pervasive, and destructive phenomenon.
Presenter: Mr Steve Hanson, Director, Bureau of Treatment, OASOS, Albany, NY, USA
10.15am - 10.45am
MORNING TEA
10.45am - 11.45am
The Alcohol and Other Drug Treatment Court (AODTC) Model
In 1997 the US National Association of Drug Court Professionals (NADCP) published an document "Defining Drug Courts:The Key Components". That document set out best practices, designs and operations for courts dealing with adults with alcohol and other drug problems. In essence, the 10 Key Components define the basic elements of an AODTC. This session will explain these components and how they are integrated into the court structure to develop best practices.
Presenter: Dr. Douglas Marlowe, Chief of Science, Law & Policy, NADCP, Alexandria, Virginia, USA
11.45am - 12.45pm
Why these 10 Key Components? Because they work!
The independent company NPC Research has evaluated over 100 AODTCs in the United States in an effort to determine what works. Their most recent research evaluated the 10 Key Components and identities which drug court practices are associated with lower recidivism and higher cost saving.
Presenters: Dr. Mike Finigan, President and Dr. Shannon Carey, Vice-President/Senior Research Assistant NPC Research, Portland, Oregon, USA
12.45pm - 2.00pm
LUNCH - PROVIDED AT CONFERENCE VENUE
2.00pm - 3.00pm
Targeting: For whom do AODTCs work best?
Adult courts targeting high risk/high need offenders have the best outcomes. These "high value" cases are traditionally among the most costly in the justice system (due to recidivism, repeated treatment failures and victim issues). Research in the United States has proven that high risk/high need offenders have greater success in AODTCs than in any other intervention in US justice system history. This presentation will outline the defining characteristics of the high risk/high need offenders, offer insight into accurately assessing for high risk/high need, discuss the research into the success of these defendants in AODTCs and address the difficulties raised when this population is grouped together with lower risk, lower need individuals.
Presenter: Dr. Douglas Marlowe, Chief of Science, Law & Policy, NADCP, Alexandria, Virginia, USA
3.00pm - 3.30pm
AFTERNOON TEA
3.30pm - 4.30pm
Identifying the AODTC Team and the role of each of its members
The AODTC team comprises the Judge, prosecutor, defence counsel, case manager, and Alcohol and Drug Treatment professional. Each member of the team is essential to ensure the best possible outcome. To properly participate, each team member must understand his/her role, and the role of others on the team.
Presenters: Judge Peggy Hora (Ret.) California Superior Court, USA and Yvonne Smith Segars, Attorney, formally Public Defender, Office of the Public Defender, State of New Jersey
4.30pm - 5.15pm
Open Question Time
Our presenters will answer questions and explore issues in response to questions raised by a panel of New Zealanders representing judiciary, police, defence bar, AOD treatment community and victims of crime.
5.15pm - 6.30pm
An opportunity to mix informally with our overseas guests and colleagues.
DAY 2
8.45am - 9.00am
Welcome and introduction to Day 2
9.00am - 10.00am
Separate Streams for Drink-Drivers: Why separate streams, how effective are they, and what are their distinguishing features?
The US has successfully developed a separate stream targeting the recidivist drink or drugged driver (the Driving While Impaired (DWI)/Driving Under the Influence (DUI) courts/streams). This session will focus on describing what a DWI/DUI court/stream is and identify the 10 guiding principles.
Presenter: Mr David Wallace, Senior Director, National Centre for DWI Courts, NADCP, Alexandria, Virginia, USA
Concurrent Streams
These will run from 10.00am, providing delegates with the opportunity to choose those sessions of most interest to them.
MORNING TEA will be available from 10.00am - 12noon with delegates invited to pick up refreshments between sessions so no formal break is needed.
10.00 - 11.45am
First Concurrent Session -
choose from the following three sessions:
Session A1: Role of prosecution and defence counsel
Prosecution and defence have a key role to play as members of the drug court team (particularly given that it is a post-plea but pre-sentence model). This session will examine the specific role of prosecution and defence on the team from the perspective of experienced counsel. The prosecutor has a duty to protect public safety, but must shed some of his/her traditional roles and work as part of the team. Defence counsel may need to shed some of his/her adversarial tactics to enhance the best possible outcome for the client.
Presenters: Mr David Wallace, Senior Director, NADCP, National Centre and Yvonne Smith Segars, Attorney, formally Public Defender, Office of the Public Defender, State of New Jersey. Commentary by Judge Peggy Hora (Ret.) California Superior Court, USA
Session A2: Ethics for treatment providers
This session will focus on providing strategies for recognising and resolving the vexed issues and dilemmas that arise for treatment professionals working for drug and alcohol addicted drug court participants. It will focus on the dynamics of ethical conduct and misconduct when providing court treatment, identify the five most common ethical pitfallsfacing providers and how to navigate around them, and identify how treatment providers can ethically collaborate and communicate with court team members, while respecting the privacy and confidentiality of participants.
Presenter: Mr Steve Hanson, Director, Bureau of Treatment, OASAS, Albany, NY, USA
Session A3: Effective evaluation of Therapeutic Courts
Monitoring and evaluation to measure the achievement of programme goals and gauge effectiveness is one of the 10 Key Components of AODTCs. NPC Research has undertaken a number of evaluations of numerous AODTCs and other Therapeutic Courts and in this session its President and Senior Researcher will provide practical advice on how to build an effective evaluation of your therapeutic court from the bottom up, using its work with AODTCs to provide examples of the process.
Presenters: Dr Mike Finnigan, President and Dr Shannon Carey, Vice-President/Senior Research Assistant NPC Research, Portland, Oregon, USA
11.45pm - 1.00pm
Second Concurrent Session -
choose one from the following three sessions:
Session B1: Incentives and sanctions
Incentives and sanctions are essential tools of the drug court team, used to shape and modify the participant's behaviour - incentives being offered for positive behaviours and sanctions for negative ones. Over the past years, the National Drug Court Institute (NDCI) has completed a thorough literature review of over 100 articles pertaining to the shaping of behaviour. This session will offer an in-depth analysis of the 10 science-based principles of changing behaviour and identify practical applications of those principles to develop a comprehensive strategy on incentives and sanctions.
Presenters: Dr Douglas Marlowe, Chief of Science, Law & Policy, NADCP, Alexandria, Virginia, USA and Judge Peggy Hora (Ret.) California Superior Court, USA
Session B2: Marijuana and Alcohol
Neuro-imaging has yielded new evidence about the effects of marijuana use and alcohol consumption on the brain. This presentation will focus on those new findings and what they mean for treatment.
Presenter: Dr Kenneth Robinson, President, Correctional Counselling, Germantown, Tennessee, USA
Session B3: Designer Drugs: Keeping up with the trends
Designer drugs are not new but they do represent an emerging threat to AODTC practitioners. Forewarned is forearmed. This session will discuss the emergence of new designer drugs, such as synthetic cannabinoids, and what's coming next. It will also focus on the difficulties of detecting designer drugs through drug tests.
Presenter: Mr Steven Hanson, Director, Bureau of Treatment, OASAS, Albany, USA
1.00pm - 2.00pm
LUNCH - Provided at Conference Venue
2.00pm - 3.30pm
Third Concurrent Session -
choose one from the following three sessions:
Session C1: Moral Reconation Therapy (MRT)
Moral Reconation Therapy is a systematic, cognitive behavioural treatment system, designed for offender populations and widely used in AODTCs. MRT is designed to alter how offenders think and how they make decisions about right and wrong.
Moral Reconation Therapy:
- Addresses the unique needs of offender populations including criminological factors, values, beliefs, behaviours, and attitudes.
- Enhances ego, social and moral growth in a step-by-step fashion.
- Develops a strong sense of personal identity with behaviour and relationships based upon higher levels of moral judgment.
- Re-educates clients socially, morally and behaviourally to instil appropriate goals, motivation and values.
- Is easy to implement in ongoing, open-ended groups with staff trained in the method.
Presenter: Dr Kenneth Robinson, President, Correctional Counselling, Germantown, Tennessee, USA
Session C2: Methamphetamine - relapse prevention
Whilst methamphetamine addiction is a treatable condition, there appears to be an especially high rate of relapse amongst many meth addicts. This presentation will explore the physiological, psychological and environmental factors of this population, and outline the critical components of effective methamphetamine recovery maintenance.
Presenter: Mr Steve Hanson, Director, Bureau of Treatment, OASAS, Albany, NY, USA
Session C3: Ethical issues for Judges and Lawyers
AODTCs modify the role of Judges and lawyers in ways that may raise ethical concerns. This session will discuss the prosecutor's natural concern for public safety, and the defence lawyer's role in a non-adversarial, collaborative programme. It will also address concerns the Judges may have, such as having ex-parte communications and direct dialogue with the AODTC participant.
Presenter: Judge Peggy Hora (Ret.) California Superior Court, USA
3.30pm - 3.45pm
AFTERNOON TEA
3.45pm - 4.30pm
Where to now for New Zealand Courts?
This session will bring together key New Zealand professionals to represent the interests of the Ministry of Justice, the judiciary, the police, the legal profession, the AOD treatment community, and victims of crime to discuss how we will move forward now in the establishment of our own AODTCs.
4.30pm - 5.00pm
FINAL COMMENTS by Judge Peggy Hora
CONFERENCE CLOSURE
FOR ALL ONLINE REGISTRATIONS PLEASE EMAIL cle@adls.org.nz AFTER YOU HAVE REGISTERED TO ADVISE YOUR SESSION CHOICES FOR DAY 2 (eg. A1, B2, C3).